BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36167880)

  • 1. Radiotherapy-induced oxidative stress and fibrosis in breast cancer are suppressed by vactosertib, a novel, orally bioavailable TGF-β/ALK5 inhibitor.
    Park J; Choi J; Cho I; Sheen YY
    Sci Rep; 2022 Sep; 12(1):16104. PubMed ID: 36167880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer.
    Choi J; Park J; Cho I; Sheen Y
    Radiol Oncol; 2022 Apr; 56(2):185-197. PubMed ID: 35390248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling.
    Oh CJ; Kim JY; Choi YK; Kim HJ; Jeong JY; Bae KH; Park KG; Lee IK
    PLoS One; 2012; 7(10):e45870. PubMed ID: 23056222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling.
    Oh CJ; Kim JY; Min AK; Park KG; Harris RA; Kim HJ; Lee IK
    Free Radic Biol Med; 2012 Feb; 52(3):671-682. PubMed ID: 22155056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
    Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
    Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of NOX2 and NOX4 Mediated by TGF-β Signaling Pathway Exacerbates Cerebral Ischemia/Reperfusion Oxidative Stress Injury.
    Lou Z; Wang AP; Duan XM; Hu GH; Song GL; Zuo ML; Yang ZB
    Cell Physiol Biochem; 2018; 46(5):2103-2113. PubMed ID: 29723859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulforaphane mitigates muscle fibrosis in mdx mice via Nrf2-mediated inhibition of TGF-β/Smad signaling.
    Sun C; Li S; Li D
    J Appl Physiol (1985); 2016 Feb; 120(4):377-90. PubMed ID: 26494449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer.
    Lee JE; Lee P; Yoon YC; Han BS; Ko S; Park MS; Lee YJ; Kim SE; Cho YJ; Lim JH; Ryu JK; Shim S; Kim DK; Jung KH; Hong SS
    Biomed Pharmacother; 2023 Jun; 162():114716. PubMed ID: 37086509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-E2-Related Factor 2 Suppresses Intestinal Fibrosis by Inhibiting Reactive Oxygen Species-Dependent TGF-β1/SMADs Pathway.
    Guan Y; Tan Y; Liu W; Yang J; Wang D; Pan D; Sun Y; Zheng C
    Dig Dis Sci; 2018 Feb; 63(2):366-380. PubMed ID: 28815354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chalcone flavokawain A attenuates TGF-β1-induced fibrotic pathology via inhibition of ROS/Smad3 signaling pathways and induction of Nrf2/ARE-mediated antioxidant genes in vascular smooth muscle cells.
    Hseu YC; Yang TY; Li ML; Rajendran P; Mathew DC; Tsai CH; Lin RW; Lee CC; Yang HL
    J Cell Mol Med; 2019 Feb; 23(2):775-788. PubMed ID: 30549180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of TGF-β signalling in combination with nal-IRI plus 5-Fluorouracil/Leucovorin suppresses invasion and prolongs survival in pancreatic tumour mouse models.
    Hong E; Park S; Ooshima A; Hong CP; Park J; Heo JS; Lee S; An H; Kang JM; Park SH; Park JO; Kim SJ
    Sci Rep; 2020 Feb; 10(1):2935. PubMed ID: 32076068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brd4 inhibition attenuates unilateral ureteral obstruction-induced fibrosis by blocking TGF-β-mediated Nox4 expression.
    Zhou B; Mu J; Gong Y; Lu C; Zhao Y; He T; Qin Z
    Redox Biol; 2017 Apr; 11():390-402. PubMed ID: 28063381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene.
    Hageman J; Eggen BJ; Rozema T; Damman K; Kampinga HH; Coppes RP
    Clin Cancer Res; 2005 Aug; 11(16):5956-64. PubMed ID: 16115939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnosic acid attenuates unilateral ureteral obstruction-induced kidney fibrosis via inhibition of Akt-mediated Nox4 expression.
    Jung KJ; Min KJ; Park JW; Park KM; Kwon TK
    Free Radic Biol Med; 2016 Aug; 97():50-57. PubMed ID: 27212017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
    Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK
    Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition and oxidative stress via the Nrf2/HO-1 signaling pathway in the human peritoneal mesothelial cell line HMrSV5.
    Zhao J; Shi J; Shan Y; Yu M; Zhu X; Zhu Y; Liu L; Sheng M
    Cell Mol Biol Lett; 2020; 25():33. PubMed ID: 32514269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trichostatin A inhibits transforming growth factor-β-induced reactive oxygen species accumulation and myofibroblast differentiation via enhanced NF-E2-related factor 2-antioxidant response element signaling.
    Yang L; Qu M; Wang Y; Duan H; Chen P; Wang Y; Shi W; Danielson P; Zhou Q
    Mol Pharmacol; 2013 Mar; 83(3):671-80. PubMed ID: 23284002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydroquercetin protects against renal fibrosis by activating the Nrf2 pathway.
    Wang W; Ma BL; Xu CG; Zhou XJ
    Phytomedicine; 2020 Apr; 69():153185. PubMed ID: 32120244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vactosertib, a Novel, Orally Bioavailable Activin Receptor-Like Kinase 5 Inhibitor, Promotes Regression of Fibrotic Plaques in a Rat Model of Peyronie's Disease.
    Song KM; Chung DY; Choi MJ; Ghatak K; Minh NN; Limanjaya A; Kwon MH; Ock J; Yin GN; Kim DK; Ryu JK; Suh JK
    World J Mens Health; 2020 Oct; 38(4):552-563. PubMed ID: 31496148
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Peng LY; An L; Sun NY; Ma Y; Zhang XW; Liu WH; Liu BL; Li P; Chen J
    Am J Chin Med; 2019; 47(5):1113-1131. PubMed ID: 31352786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.